Key facts
- It has raised $210K.
- Notable investors include GrowthX Capital.
- Symbio Bioculinary has filed 1 Form D with the SEC, most recently Jun 2025 ($120K sold to 2 investors).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Symbio Bioculinary
- ·The full record, as it builds
Funding rounds
No funding rounds for Symbio Bioculinary are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Symbio Bioculinary
Operator of a bioprocessing platform intended to convert food waste into usable food ingredients. The company's platform offers on-site processing systems using engineered fungi and enzymatic conversion, enabling food producers and processing facilities to transform waste into ingredients and manage byproducts efficiently.
- Sector
- Healthcare
- HQ
- Bloomington, IL, United States
- Founded
- 2022
- Employees
- 3
- Website
- symbiobc.com/
- Ownership
- Privately Held (backing)
Symbio Bioculinary doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Symbio Bioculinary shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Symbio Bioculinary in its N-PORT filings yet. We sweep new filings monthly.